Filariasis
11
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (11)
Host Response to Infection and Treatment in Filarial Diseases
Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)
PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India
A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali
Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Relative Bioavailability Study of Emodepside IR-tablets and Solution
Medical Implications of Coinfection With Malaria and Filariasis Parasites
Exhaled NO Testing in Filariasis